Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Friday, July 26, 2024.
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
Strong Uptrend (+100) - CRVS is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, CRVS continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid CRVS?
MarketClub looks at technical strength and momentum to determine if the timing is right for CRVS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CRVS
The long-term trend has been UP since Jul 26th, 2024 at 2.35
The intermediate-term trend has been UP since Jul 12th, 2024 at 2.04
The short-term trend has been UP since Jul 26th, 2024 at 2.33
Smart Scan Analysis for CRVS
Based on our trend formula, CRVS is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 2.310 | 2.630 | 2.300 | 2.585 | +0.275 |
| Prev. Close | Volume | Bid | Ask | Time |
| 2.310 | 404696 | 2024-07-26 15:59:59 |
| Year High | 13.91 | Year High Date | 2018-06-15 |
| Year Low | 5.66 | Year Low Date | 2018-11-28 |
| 52wk High | 2.58 | 52wk High Date | 2024-02-09 |
| 52wk Low | 1.05 | 52wk Low Date | 2023-10-30 |
| Average Volume | 130,561 | Shares Outstanding | 62,551 |
| Market Cap | 121M | Assets | 40,084,000M |
| Liabilities | 6,720,000M | P/E Ratio | 21.5714 |
| Volatility | 63.98 |